Modern Slavery & Human Trafficking Statement
AcedrA Pharmaceutical Company LLC.
Introduction
AcedrA BioPharmaceuticals takes a robust approach to modern slavery and human trafficking. We are committed to ethical conduct and to systems that aim to prevent these practices in our business and supply chains. We are a next-generation partner to pharma, biotech and healthcare, providing clinical trial services, early access programs and product commercialization.
Our supply chain
We source products as close to the manufacturer as possible, using authorized distributors where direct sourcing is not feasible. Sourcing partners are licensed by local authorities and audited against industry standards, products are physically inspected to confirm authenticity, and transport follows Good Distribution Practice (GDP).
Policies
We maintain an Anti-Slavery Policy and a Code of Conduct that asks employees to act professionally and to respect the human rights of others.
Due diligence
We communicate our anti-slavery standards to suppliers and expect them to meet the same standards. The Board, represented by the CEO, communicates the importance of ethics and legal compliance to employees.
Training
The Code of Conduct guides our dealings with customers, suppliers and partners. Staff are encouraged to raise concerns and all staff are trained on the anti-slavery policy.
Further steps
- Raise awareness of modern slavery through communications and training
- Subject new suppliers and manufacturers to due diligence, including compliance with anti-trafficking laws
- Establish a formal corporate responsibility governance structure reporting to the Board
- Review our policies to ensure adequate protection against modern slavery
Legal basis and contact
This statement is made under Saudi Arabia's Anti-Trafficking in Persons Law (Royal Decree No. M/40). Contact: Board of Directors, CEO Department or Compliance Department, toll-free 8001240411, legal.affairs@acedrarx.com.